$AKZOF

AKZO NOBEL NV (AKZOF): Financial results for Q3 2026

AKZO NOBEL NV (AKZOF) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Our results at a glance Highlights Q3 2026 (compared with Q3 2025) • Organic sales growth of 2% on pricing; revenue flat • Operating income impacted by the Russia deconsolidation and the Pakistan divestment • Organic adjusted EBITDA growth 1 of €15 million; adjusted

Original reporting
Published Oct 21, 2026, 12:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 12:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AKZOF
Bearish
high confidence
Mentioned
$AKZOF
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$AKZOFBearishHigh
01

Why it matters

The earnings miss may trigger short‑term sell‑off, but the announced EBITDA improvement target and upcoming Axalta merger could support a rebound.

02

Market read

Primary impact on AkzoNobel stock; secondary effect on European industrials and paint sector.

03

What to watch

Potential cost synergies from the pending Axalta merger and improved pricing power in 2027.

Relevance 7/10Novelty 8/10Timing: today

Background

AkzoNobel, a Dutch paints and coatings maker, filed its Q3 2026 results via SEC Form 6‑K.

Company-level read

Ticker impact

$AKZOFBearishHigh confidence
Context

Q3 2026 earnings release showing flat revenue, negative operating income and modest EBITDA margin improvement.

Expected impact

likely pressure as investors price in weaker operating results and divestments

Evidence & confidence

Flat revenue, negative operating income and guidance only modestly above prior year indicate limited upside.

Market effects

Paints and coatings sector may see broader scrutiny on margins and divestment impacts.

European markets could react to the earnings miss.

Limited, primarily affecting AkzoNobel and its peers.

Counterpoint

If the company successfully completes the Axalta merger, long-term upside could outweigh short-term earnings weakness.

Key entities

  • AkzoNobel NV

    Dutch paints and coatings manufacturer.

  • Axalta Coating Systems

    Target of pending merger with AkzoNobel.

Related articles

$AKZOYMedAI 8/10

AkzoNobel (AKZOF) investors approve all-share Axalta merger

AkzoNobel shareholders approved all resolutions for the proposed all-share merger with Axalta at an Aug. 5, 2026 extraordinary general meeting, including merger approval, share issuance, board appointments and remuneration policy. Axalta shareholders also voted in favor. The deal moves to regulatory review and other closing conditions, with completion expected end-2026 or early 2027.

$SBCFMed

Seacoast Q3 2026 slides: profitability surges, integration complete

Seacoast Banking Corporation (SBCF) reported Q3 2026 earnings with adjusted EPS of $0.66, beating estimates. Net income rose 64% YoY to $59.9M, while net interest income increased 37% YoY to $185.4M. The bank's stock traded at $33.09, down 1.91% from the prior close, with a market cap of $3.17B. Integration from the Citizens First Bank acquisition is complete, and the bank is focusing on organic growth and technology investments.

$AOSMed

A.O. Smith set to report earnings as China divestiture looms

A.O. Smith (AOS) is set to report Q3 earnings, with analysts expecting EPS of $0.90 and revenue of $963.1M, down from Q2. The company plans to divest 81% of its China operations, valued at $400M. Analysts have a neutral consensus with a $66.20 price target. Margin pressure from steel costs and declining water heater volumes are key concerns.